Thioredoxin-1 protects against androgen receptor-induced redox vulnerability in castration-resistant prostate cancer.

Samaranayake, Govindi J; Troccoli, Clara I; Huynh, Mai; Lyles, Rolando D Z; Kage, Karen; Win, Andrew; Lakshmanan, Vishalakshi; Kwon, Deukwoo; Ban, Yuguang; Chen, Steven Xi; Zarco, Enrique Rodriguez; Jorda, Merce; Burnstein, Kerry L; Rai, Priyamvada.
Nat Commun; 8(1): 1204, 2017 10 31.
Artigo em Inglês | MEDLINE | ID: mdl-29089489